Pharmaceuticals - Union Register


List of nationally authorised medicinal products for human use


Product name: Bromocriptine
Also marketed in the EU under the name(s): Brameston, Bromergon, Bromocorn, Bromocriptin AbZ, bromocriptin-ct, Bromocriptin-ratiopharm, Bromocriptin-Richter, Bromocriptina, Bromocriptine, Bromocriptine Sopharma, Bromocriptine Zentiva, Medocriptine, Parlodel, Pirodal, Pravidel, Teva UK Bromocriptine
Active substance: bromocriptine
Indication: Bromocriptine is used to prevent or suppress lactation in women who have given birth.
Marketing Authorisation Holder: Not applicable

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
3/11/2014 Referral EMEA/H/A-31/1379 (2014)8296 of 30/10/2014